| Isabella Zornes, | |
|
65 Shenandoah Ave Ste 201, Daleville, VA 24083-3205 | |
| (540) 591-7514 | |
| Not Available |
| Full Name | Isabella Zornes |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 65 Shenandoah Ave Ste 201, Daleville, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043986946 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Isabella Zornes, 10 Church Ave Sw Apt 221, Roanoke, VA 24011-2024 Ph: (304) 916-3523 | Isabella Zornes, 65 Shenandoah Ave Ste 201, Daleville, VA 24083-3205 Ph: (540) 591-7514 |
News Archive
Wolters Kluwer Pharma Solutions, a leading provider of scientific information and analytics to pharmaceutical and healthcare professionals, today announced the signing of an 8-year lease on 70,000 square feet of new office space in the Biltmore Financial Center office park in Phoenix, AZ.
While declines in U.S. hospital admissions during the onset of COVID-19 has been well-documented, little is known about how admissions during the rebound varied by age, insurance coverage and socioeconomic groups.
A new Guidance recently published by the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the International Osteoporosis Foundation (IOF) reflects the most current advances in the diagnosis and management of osteoporosis, the 'silent disease' which affects up to one in two postmenopausal women.
The Society for Integrative Oncology (SIO) announced today that National Institutes of Health Director Francis Collins, MD, PhD, will deliver the keynote address at its eighth international conference, which is co‐sponsored by Case Western Reserve University School of Medicine.
AVEO Pharmaceuticals, Inc. today announced that previously reported positive clinical data evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC) will be featured in several poster presentations at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17-19, 2011 at the Orlando World Center Marriott in Orlando, Fla.
› Verified 8 days ago
Marta Timmermann, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Shenandoah Ave Ste 201, Daleville, VA 24083 Phone: 540-591-7514 | |
Mrs. Lilly Redman Adams, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Shenandoah Ave Ste 201, Daleville, VA 24083 Phone: 540-591-7514 | |
Sara Helen Terwilliger, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Shenandoah Ave Ste 201, Daleville, VA 24083 Phone: 540-591-7514 | |
Emily Welch, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Shenandoah Ave Ste 201, Daleville, VA 24083 Phone: 540-591-7514 | |
Rachel Lawson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 44 Catawba Rd, Daleville, VA 24083 Phone: 540-992-4801 |